Table 2.
Mean weighted scores achieved by participants throughout the study.
| Baseline | Post 1st consult | Long term follow up | ||||
|---|---|---|---|---|---|---|
|
Control n = 29 (%) |
iPad n = 25 (%) |
Control n = 27 (%) |
iPad n = 23 (%) |
Control n = 25 (%) |
iPad n = 22 (%) |
|
| Vaccination | 44.8 | 50.1 | 49.4 | 58.7 | 57.3 | 50.0 |
| Horizontal transmission | 51.8 | 64.0 | 57.9 | 82.6 | 63.3 | 75.3 |
| Vertical transmission | 47.2 | 54.0 | 58.0 | 72.5 | 51.3 | 58.3 |
| Complications | 75.9 | 74.0 | 83.3 | 91.3 | 66.0 | 88.6 |
| Management | 57.3 | 56.0 | 59.7 | 76.6 | 60.0 | 75.0 |
| Stigma | 48.3 | 64.0 | 48.0 | 79.6 | 72.0 | 68.2 |
| Total | 55.2 | 61.4 | 61.5 | 79.5 | 61.0 | 72.6 |